Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

MicroRNAs01:22

MicroRNAs

4.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

24.4K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.4K
Abnormal Proliferation02:23

Abnormal Proliferation

5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

2.9K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.9K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

7.5K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of blood flow restriction training timing: Does exercising at dusk or dawn enhance response?

Physiological reports·2025
Same author

The Tandem Reconnection and Cusp Electrodynamics Reconnaissance Satellites (TRACERS) Mission.

Space science reviews·2025
Same author

Early versus late infectious complications following chimeric antigen receptor-modified T-cell therapy.

Leukemia & lymphoma·2024
Same author

Growth velocity of fetal sacrococcygeal teratoma as predictor of perinatal morbidity and mortality: multicenter study.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2024
Same author

Cryo-EM Structure of AAV2 Rep68 bound to integration site AAVS1: Insights into the mechanism of DNA melting.

bioRxiv : the preprint server for biology·2024
Same author

Non-invasive cell-free DNA prenatal screening for trisomy 21 as part of primary screening strategy in twin pregnancy.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2023
Same journal

Single-cell architecture of purinergic signaling in human cord blood hematopoietic stem and progenitor cells.

Leukemia·2026
Same journal

Feasibility and safety of rapid glofitamab ramp-up.

Leukemia·2026
Same journal

Single-cell DNA methylation analysis uncovers epigenetic pathways in the transformation of MDS to AML.

Leukemia·2026
Same journal

PD-L2 is associated with lineage-related transcriptional programs distinct from PD-L1 in primary mediastinal large B-cell lymphoma.

Leukemia·2026
Same journal

Lineage-restricted dependency on an oncofetal SNHG29-IGF2BP1 RNA axis in acute megakaryoblastic leukemia.

Leukemia·2026
Same journal

Selective targeting of RSK signaling with PMD-026 suppresses FLT3-activated acute myeloid leukemia while sparing normal hematopoiesis.

Leukemia·2026
See all related articles

Related Experiment Video

Updated: Mar 1, 2026

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

9.0K

MUC1 inhibition leads to decrease in PD-L1 levels via upregulation of miRNAs.

A R Pyzer1, D Stroopinsky1, J Rosenblatt1

  • 1Department of Medicine, Beth Israel Deaconess Medical Center, Hematology/Oncology, Harvard Medical School, Boston, MA, USA.

Leukemia
|May 31, 2017
PubMed
Summary
This summary is machine-generated.

MUC1 oncoprotein regulates PD-L1 expression in acute myeloid leukemia (AML) post-transcriptionally via microRNAs. Targeting MUC1 enhances anti-tumor immunity by increasing leukemia-specific T cells.

More Related Videos

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

3.3K
Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
07:09

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

8.0K

Related Experiment Videos

Last Updated: Mar 1, 2026

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

9.0K
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

3.3K
Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
07:09

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

8.0K

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • The PD-L1/PD-1 pathway is crucial for immune suppression in acute myeloid leukemia (AML).
  • The regulatory mechanisms of PD-L1 in AML remain largely unknown.
  • MUC1 oncoprotein's role in PD-L1 regulation in AML was investigated.

Purpose of the Study:

  • To investigate the role of MUC1 oncoprotein in modulating PD-L1 expression in AML.
  • To elucidate the post-transcriptional mechanisms regulating PD-L1 in AML.
  • To evaluate MUC1 as a potential therapeutic target for enhancing anti-tumor immunity in AML.

Main Methods:

  • MUC1 silencing in AML cell lines and a murine AML model.
  • Analysis of PD-L1 mRNA and protein levels.
  • MicroRNA profiling using NanoString arrays.
  • Assessment of T-cell activity and sensitivity to T-cell-mediated lysis.

Main Results:

  • MUC1 silencing suppressed PD-L1 expression post-transcriptionally.
  • miR-200c and miR-34a were identified as key regulators, with their levels increasing upon MUC1 silencing.
  • MUC1 signaling decreased DICER expression, affecting microRNA processing.
  • Targeting MUC1 in vivo increased leukemia-specific T cells and enhanced AML cell sensitivity to T-cell lysis.

Conclusions:

  • MUC1 is a critical regulator of PD-L1 expression in AML through microRNA modulation.
  • MUC1 impacts microRNA processing via regulation of DICER and c-Jun activity.
  • Targeting MUC1 represents a promising strategy to enhance anti-tumor immunity in AML.